Učitavanje...
Inverting the BTK-BCL2 order
In this issue of Blood, Lin et al report the first long-term follow-up data showing that Bruton tyrosine kinase inhibitors (BTKi's) are effective in chronic lymphocytic leukemia (CLL) after previous progression on venetoclax.(1)
Spremljeno u:
| Izdano u: | Blood |
|---|---|
| Glavni autor: | |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Hematology
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7316207/ https://ncbi.nlm.nih.gov/pubmed/32556131 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2020005886 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|